Colgate-Palmolive Company (NYSE:CL) Shares Acquired by Galibier Capital Management Ltd.

Galibier Capital Management Ltd. boosted its holdings in Colgate-Palmolive Company (NYSE:CL - Free Report) by 1,119.3% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,631 shares of the company's stock after purchasing an additional 13,431 shares during the quarter. Colgate-Palmolive comprises approximately 0.4% of Galibier Capital Management Ltd.'s portfolio, making the stock its 22nd biggest position. Galibier Capital Management Ltd.'s holdings in Colgate-Palmolive were worth $1,371,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in CL. Westend Capital Management LLC lifted its position in shares of Colgate-Palmolive by 111.1% during the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock valued at $25,000 after acquiring an additional 140 shares during the period. Cornerstone Planning Group LLC lifted its holdings in Colgate-Palmolive by 1,913.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after purchasing an additional 287 shares in the last quarter. Vermillion Wealth Management Inc. acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth $31,000. Wintrust Investments LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth $33,000. Finally, Accredited Wealth Management LLC purchased a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $34,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CL. JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research note on Monday, April 28th. Barclays reduced their price target on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a research report on Friday, April 11th. Piper Sandler reduced their price target on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research report on Monday, March 31st. UBS Group boosted their price target on Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a research report on Thursday, April 17th. Finally, Wells Fargo & Company upped their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research report on Wednesday, April 2nd. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $101.69.

Colgate-Palmolive Stock Down 0.6%

Shares of Colgate-Palmolive stock opened at $91.58 on Thursday. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96. The firm has a market cap of $74.22 billion, a P/E ratio of 25.87, a P/E/G ratio of 4.89 and a beta of 0.37. Colgate-Palmolive Company has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The business has a 50-day moving average price of $90.65 and a 200 day moving average price of $90.55.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.05. The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. Colgate-Palmolive's quarterly revenue was down 3.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.86 earnings per share. On average, sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be issued a dividend of $0.52 per share. The ex-dividend date is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.27%. Colgate-Palmolive's dividend payout ratio (DPR) is 58.76%.

Colgate-Palmolive announced that its Board of Directors has authorized a share buyback program on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to repurchase up to 6.8% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board believes its shares are undervalued.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.